0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2006;296(24):2889. doi:10.1001/jama.296.24.2889.
Text Size: A A A
Published online

CONTINUING VS STOPPING ALENDRONATE AFTER 5 YEARS

Bisphosphonate therapy reduces the risk of fractures in women with postmenopausal osteoporosis, but the optimal duration of therapy is not known. In the randomized Fracture Intervention Trial Long-term Extension (FLEX) trial, investigators compared the effects on bone mineral density (BMD) of 5 years vs 10 years of alendronate therapy in a cohort of postmenopausal women. Black and colleaguesArticle report that women who discontinued alendronate at 5 years experienced moderate declines in BMD, although not to their pretreatment level, and a gradual increase in biochemical markers of bone turnover compared with women who continued therapy for 10 years. In exploratory analyses, the authors found that nonvertebral fracture risks were similar in both groups and clinically detected vertebral fractures were higher in women who discontinued therapy. In an editorial, Colón-EmericArticle discusses the implications of the FLEX trial results for women with osteoporosis.

FIFTY-YEAR TRENDS IN STROKE

Carandang and colleagues analyzed data from participants in the Framingham Study, original and offspring cohorts, who were free of prevalent stroke to assess temporal trends in stroke incidence, lifetime risk, severity, and 30-day mortality from 1950 through 2004. The authors found that stroke incidence decreased over time, but lifetime risk did not decline significantly. Stroke severity remained relatively stable, and 30-day mortality decreased significantly in men but not in women.

PROTON PUMP INHIBITORS AND RISK OF HIP FRACTURE

Proton pump inhibitor (PPI) therapy may affect bone through 2 opposing actions—reducing calcium absorption as a result of PPI-induced hypochlorhydria and reducing bone resorption through inhibition of osteoclastic vacuolar proton pumps. To investigate the net effect of PPI therapy on the risk of hip fracture, Yang and colleagues conducted a nested case-control study of patients who were 50 years and older and were users of PPI therapy or nonusers of acid suppressive therapy. The authors found a significantly increased risk of hip fracture among persons taking PPIs for more than 1 year. The risk of fracture increased with higher-dose therapy and longer duration of use.

PFO AND HIGH-ALTITUDE PULMONARY EDEMA

Individuals who are prone to high-altitude pulmonary edema (HAPE) have exaggerated pulmonary hypertension and arterial hypoxemia at high altitude for reasons that are not clear. Limited evidence has suggested that a patent foramen ovale (PFO) might be a contributing factor. Allemann and colleagues investigated this possibility in a case-control study of HAPE-prone and HAPE-resistant mountaineers who underwent transesophageal echocardiography, Doppler echocardiography, and pulse oximetry at low and high altitude. The investigators found that the frequency of PFO was significantly higher in HAPE-prone than in HAPE-resistant persons. At high altitude, HAPE-prone individuals with a large PFO had more severe hypoxemia compared with persons having a small PFO or closed foramen ovale.

A PIECE OF MY MIND

“When you name something, it's as it you give it life. My thyroid cancer was born on Monday, June 12.” From “A Bump in the Neck.”

MEDICAL NEWS & PERSPECTIVES

Experts are trying to understand and reverse persistently increasing rates of preterm birth in the United States by promoting more research and by testing novel interventions.

CLINICIAN'S CORNER

End-of-life care for homeless patients is discussed in the case of Mr K, a 66-year-old man with metastatic renal cell carcinoma, who has been homeless for much of the past 50 years.

POVERTY AND HUMAN DEVELOPMENT

Authors may submit manuscripts for a JAMA theme issue on poverty and human development.

AUTHOR IN THE ROOM TELECONFERENCE

Join Dennis Black, PhD, January 17, 2007, from 2 to 3 PM eastern time to discuss the effects of continuing or stopping alendronate after 5 years. To register, go to http://www.ihi.org/AuthorintheRoom.

JAMA PATIENT PAGE

For your patients: Information about patent foramen ovale.

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.